EPS for The Toronto-Dominion Bank (TD) Expected At $1.49; Letko Brosseau & Associates Has Trimmed Abbvie (ABBV) Stake By $1.44 Million

May 18, 2018 - By David King

The Toronto-Dominion Bank (TSE:TD) Logo

Letko Brosseau & Associates Inc decreased Abbvie Inc (ABBV) stake by 2.34% reported in 2017Q4 SEC filing. Letko Brosseau & Associates Inc sold 14,975 shares as Abbvie Inc (ABBV)’s stock declined 6.31%. The Letko Brosseau & Associates Inc holds 624,572 shares with $60.40M value, down from 639,547 last quarter. Abbvie Inc now has $167.13B valuation. The stock increased 0.27% or $0.28 during the last trading session, reaching $105.32. About 6.70M shares traded. AbbVie Inc. (NYSE:ABBV) has risen 39.20% since May 18, 2017 and is uptrending. It has outperformed by 27.65% the S&P500.

Analysts expect The Toronto-Dominion Bank (TSE:TD) to report $1.49 EPS on May, 24 before the open.They anticipate $0.15 EPS change or 11.19% from last quarter’s $1.34 EPS. T_TD’s profit would be $2.75 billion giving it 12.68 P/E if the $1.49 EPS is correct. After having $1.56 EPS previously, The Toronto-Dominion Bank’s analysts see -4.49% EPS growth. The stock increased 0.08% or $0.06 during the last trading session, reaching $75.59. About 2.59M shares traded. The Toronto-Dominion Bank (TSE:TD) has 0.00% since May 18, 2017 and is . It has underperformed by 11.55% the S&P500.

Analysts await AbbVie Inc. (NYSE:ABBV) to report earnings on July, 27. They expect $1.97 EPS, up 38.73% or $0.55 from last year’s $1.42 per share. ABBV’s profit will be $3.13B for 13.37 P/E if the $1.97 EPS becomes a reality. After $1.87 actual EPS reported by AbbVie Inc. for the previous quarter, Wall Street now forecasts 5.35% EPS growth.

Since December 14, 2017, it had 0 insider buys, and 11 insider sales for $47.70 million activity. Shares for $119,351 were sold by Michael Robert A.. Shares for $14.07 million were sold by Schumacher Laura J. RICHMOND TIMOTHY J. had sold 87,040 shares worth $8.57M on Monday, December 18. Another trade for 70,928 shares valued at $8.31M was sold by CHASE WILLIAM J. $157,458 worth of stock was sold by SALEKI-GERHARDT AZITA on Wednesday, February 28. $9.57M worth of AbbVie Inc. (NYSE:ABBV) shares were sold by ALBAN CARLOS. SEVERINO MICHAEL sold $311,684 worth of AbbVie Inc. (NYSE:ABBV) on Wednesday, February 28.

Among 23 analysts covering Abbvie Inc (NYSE:ABBV), 10 have Buy rating, 2 Sell and 11 Hold. Therefore 43% are positive. Abbvie Inc has $15700 highest and $6 lowest target. $101.11’s average target is -4.00% below currents $105.32 stock price. Abbvie Inc had 91 analyst reports since July 21, 2015 according to SRatingsIntel. The company was upgraded on Monday, December 7 by Jefferies. The stock of AbbVie Inc. (NYSE:ABBV) earned “Hold” rating by Deutsche Bank on Thursday, September 28. On Friday, April 27 the stock rating was maintained by Credit Suisse with “Neutral”. The firm has “Buy” rating by Jefferies given on Friday, July 14. The stock has “Buy” rating by Jefferies on Monday, May 29. Cowen & Co maintained AbbVie Inc. (NYSE:ABBV) on Friday, July 28 with “Hold” rating. As per Friday, January 26, the company rating was maintained by Cowen & Co. The firm has “Sell” rating by Societe Generale given on Wednesday, April 6. The stock of AbbVie Inc. (NYSE:ABBV) has “” rating given on Monday, September 28 by Citigroup. The rating was maintained by Jefferies on Friday, September 15 with “Buy”.

Letko Brosseau & Associates Inc increased Canadian Nat Res Ltd (NYSE:CNQ) stake by 176,045 shares to 13.94M valued at $499.63M in 2017Q4. It also upped Teck Resources Ltd (NYSE:TCK) stake by 189,403 shares and now owns 13.67M shares. Cenovus Energy Inc (NYSE:CVE) was raised too.

More notable recent AbbVie Inc. (NYSE:ABBV) news were published by: Seekingalpha.com which released: “Biotechs perk up ahead of ASCO abstract drop” on May 16, 2018, also Seekingalpha.com with their article: “AbbVie: Can Mylan Pull Off A Humira Biosimilar?” published on May 01, 2018, 247Wallst.com published: “Why One Old Stock Buyback Trick Is Working So Well for AbbVie” on May 01, 2018. More interesting news about AbbVie Inc. (NYSE:ABBV) were released by: Seekingalpha.com and their article: “AbbVie Is Still A One-Trick Pony” published on April 26, 2018 as well as Seekingalpha.com‘s news article titled: “AbbVie: Protection Kicks In” with publication date: April 25, 2018.

Investors sentiment decreased to 0.8 in 2017 Q4. Its down 0.05, from 0.85 in 2017Q3. It worsened, as 42 investors sold ABBV shares while 695 reduced holdings. 139 funds opened positions while 448 raised stakes. 1.06 billion shares or 0.35% more from 1.06 billion shares in 2017Q3 were reported. 32,160 are held by Pettee Invsts Incorporated. S&T Bancorp Pa invested in 2,342 shares or 0.04% of the stock. David R Rahn & Inc stated it has 1.76% in AbbVie Inc. (NYSE:ABBV). Bollard Grp Incorporated Limited Liability Company reported 3,794 shares. Balyasny Asset Mgmt Ltd invested in 209,227 shares or 0.06% of the stock. New York-based Jefferies Grp Incorporated Lc has invested 0.03% in AbbVie Inc. (NYSE:ABBV). Grand Jean Management holds 0.33% or 10,055 shares in its portfolio. Arizona State Retirement Systems stated it has 0.4% of its portfolio in AbbVie Inc. (NYSE:ABBV). Peapack Gladstone owns 161,017 shares for 0.84% of their portfolio. Eagleclaw Managment Ltd Limited Liability Company holds 2.58% or 52,766 shares in its portfolio. De Burlo Grp holds 0.7% of its portfolio in AbbVie Inc. (NYSE:ABBV) for 35,550 shares. Bokf Na invested 0.34% in AbbVie Inc. (NYSE:ABBV). Ironwood Financial Ltd Co has 0.01% invested in AbbVie Inc. (NYSE:ABBV). Amg Natl Trust Retail Bank accumulated 82,586 shares. Loudon Mgmt Lc reported 32,389 shares stake.

The Toronto-Dominion Bank, together with its subsidiaries, provides various personal and commercial banking services and products in Canada and the United States. The company has market cap of $139.51 billion. It operates through three divisions: Canadian Retail, U.S. It has a 13.94 P/E ratio. Retail, and Wholesale Banking.

More notable recent The Toronto-Dominion Bank (TSE:TD) news were published by: Fool.com which released: “2 Stocks to Add International Exposure to Your Portfolio” on May 15, 2018, also Bizjournals.com with their article: “Survey: More than half of small businesses anticipate revenue growth” published on May 11, 2018, Fool.ca published: “2 Top Canadian Dividend Stocks to Start Your TFSA Retirement Plan” on May 14, 2018. More interesting news about The Toronto-Dominion Bank (TSE:TD) were released by: Fool.com and their article: “How to Get International Exposure Without Buying Foreign Stocks” published on May 15, 2018 as well as Streetinsider.com‘s news article titled: “Viking Global’s 13F Shows New Stakes in Alibaba (BABA), BioMarin (BMRN) and Western Digital (WDC), Increase in …” with publication date: May 15, 2018.

AbbVie Inc. (NYSE:ABBV) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:

Recent Posts